On the Forefront of Revolutionizing Heart and Vascular Care
OhioHealth is recognized as a leader in revolutionary treatment of stroke, peripheral vascular disease and common cardiovascular conditions, such as heart valve disease and coronary artery disease.
Our robust research program keeps us at the forefront of medicine and assures that our patients consistently receive the best heart and vascular care available.
OhioHealth is currently participating in more than 100 heart and vascular clinical trials through the OhioHealth Research and Innovation Institute.
We actively support our clinicians as they explore innovations to improve patient care. Our goal is to engage in research that touches our patients lives in meaningful ways.
Our participation in clinical trials has led to the FDA-approval of numerous devices that are now improving the lives of patients every day.
Our Latest Clinical Trials
Some of our latest cardiovascular clinical trials include:
REDUCE HTN: A clinical trial evaluating a minimally invasive, catheter-based procedure using the Vessix™ Renal Denervation System to deliver low-power radiofrequency (RF) energy to disrupt the nerves surrounding the renal arteries in which hyperactivity contributes to uncontrolled high blood pressure.
Principal Investigator: Gary M. Ansel, MD, FACC
COMMENCE: A clinical trial further studying the safety and effectiveness of the FDA-approved Carpentier-Edwards PERIMOUNT Magna Mitral Ease Pericardial
Bioprosthesisa for surgical mitral valve replacement.
Principal Investigator: Jefferson M. Lyons, MD
MIMICS: A clinical trial evaluating the BioMimics 3D™ Stent System to treat blockages in the femoropopliteal arteries (located behind the knee and the back of the leg) in patients with symptomatic peripheral arterial disease (PAD).
Principal Investigator: Michael A. Jolly, MD
SCAFFOLD: A clinical trial studying the use of the GORE® Carotid Stent in patients with carotid disease, who are at risk for adverse effects from carotid endarterectomy (a surgical treatment for carotid disease).
Principal Investigator: Mitchell J. Silver, DO, FACC, FSVM
For more information on cardiovascular clinical trials being conducted at OhioHealth, talk to your physician, or contact the OhioHealth Research and Innovation Institute at (614) 566.1250.
Clinical trials at OhioHealth involve investigational drugs, devices and other products that are currently being tested in the US. Our research activities meet the highest standards of quality and safety. For more information, please visit OhioHealth's research compliance page.